445 318

Cited 5 times in

KNOW-Ped CKD (KoreaN cohort study for outcomes in patients with pediatric CKD): Design and methods

 Hee Gyung Kang  ;  Hyun Jin Choi  ;  Kyung Hee Han  ;  Seong Heon Kim  ;  Hee Yeon Cho  ;  Min Hyun Cho  ;  Jae Il Shin  ;  Joo Hoon Lee  ;  Joongyub Lee  ;  Kook Hwan Oh  ;  Young Seo Park  ;  Hae Il Cheong  ;  Curie Ahn  ;  Il-Soo Ha 
 BMC NEPHROLOGY, Vol.17 : 35, 2016 
Journal Title
Issue Date
Adolescent ; Adolescent Development ; Child ; Child Development ; Child, Preschool ; Cohort Studies ; Disease Progression ; Female ; Growth Disorders/etiology ; Humans ; Hypertension/etiology ; Hypertrophy, Left Ventricular/etiology ; Infant ; Infant, Newborn ; Kidney Failure, Chronic/complications ; Kidney Failure, Chronic/mortality ; Kidney Failure, Chronic/physiopathology* ; Kidney Failure, Chronic/therapy ; Male ; Prognosis ; Prospective Studies ; Quality of Life ; Renal Insufficiency, Chronic/mortality ; Renal Insufficiency, Chronic/physiopathology* ; Renal Replacement Therapy ; Republic of Korea ; Young Adult
Asian children ; Chronic kidney disease ; Cohort study ; Design ; Prognostic factor
BACKGROUND: The global prevalence of chronic kidney disease (CKD) is increasing. In children, CKD exhibits unique etiologies and can have serious impacts on children's growth and development. Therefore, an aggressive approach to preventing the progression of CKD and its complications is imperative. To improve the understanding and management of Asian pediatric patients with CKD, we designed and launched KNOW-Ped CKD (KoreaN cohort study for Outcome in patients With Pediatric Chronic Kidney Disease), a nationwide, prospective, and observational cohort study of pediatric CKD with funding from the Korean government. METHODS/DESIGN: From seven major centers, 450 patients <20 years of age with CKD stages I to V are recruited for the comprehensive assessment of clinical findings, structured follow-up, and bio-specimen collection. The primary endpoints include CKD progression, defined as a decline of estimated glomerular filtration rate by 50 %, and a requirement for renal replacement therapy or death. The secondary outcomes include the development of left ventricular hypertrophy or hypertension, impairment of growth, neuropsychological status, behavioral status, kidney growth, and quality of life. DISCUSSION: With this study, we expect to obtain more information on pediatric CKD, which can be translated to better management for the patients. TRIAL REGISTRATION: NCT02165878 (ClinicalTrials.gov), submitted on June 11, 2014.
Files in This Item:
T201600794.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아과학교실) > 1. Journal Papers
Yonsei Authors
Shin, Jae Il(신재일) ORCID logo https://orcid.org/0000-0003-2326-1820
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.